Recordati Acquires Opalia Pharma

News   Jul 26, 2013

 
Recordati Acquires Opalia Pharma
 
 
 

RELATED ARTICLES

Researchers Develop Novel ‘One-pot’ Approach to Conjugated Tetraenes Synthesis

News

TUAT researchers have achieved the new synthetic route of conjugated tetraenes from inexpensive and easily available 1,3-butadiene and substituted acetylenes by a one-pot approach under mild conditions. Conjugated tetraenes are important key substructures in biologically active natural products such as vitamins, and anti-mycotic drugs.

READ MORE

Safety and Efficacy of MERS Treatment Confirmed in Phase I Trial

News

An experimental treatment developed from cattle plasma for Middle East respiratory syndrome (MERS) coronavirus infection shows broad potential, according to a small clinical trial. The treatment, SAB-301, was safe and well tolerated by healthy volunteers, with only minor reactions documented.

READ MORE

Fuel Made From Shale Gas With Innovative Catalyst

News

New Research shows methane in shale gas can be turned into hydrocarbon fuels using an innovative platinum and copper alloy catalyst. The new alloy catalyst is resistant to coking, so it retains its activity and requires less energy to break the bonds than other materials.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE